Can I Take GLP-1 Medications if I'm Under 18?
Learn about GLP-1 medication eligibility for adolescents and teens, including FDA approvals, age restrictions, and what parents should know about semaglutide and tirzepatide for minors.
More on Can I Questions
Important Medical Disclaimer
This article is for informational purposes only. Weight management decisions for minors should involve pediatricians, parents or guardians, and potentially pediatric endocrinologists. Trimi serves adult patients aged 18 and older.
The Direct Answer
Some GLP-1 medications are FDA-approved for adolescents aged 12+, but most compounded and telehealth GLP-1 programs (including Trimi) require patients to be 18 or older.
Semaglutide (brand name Wegovy) received FDA approval for weight management in adolescents aged 12 and older with obesity in late 2022. This approval was based on the STEP TEENS trial showing an average 16% reduction in BMI. Liraglutide (Saxenda) has also been approved for teens 12+.
However, compounded versions of these medications are typically prescribed through adult-focused programs. If you are under 18 and considering GLP-1 therapy, you will need to work with a pediatric specialist who can prescribe brand-name medications.
What Parents Should Know
Lifestyle Interventions First
The American Academy of Pediatrics recommends comprehensive lifestyle interventions as the foundation of adolescent weight management. GLP-1 medications are considered when lifestyle changes alone are insufficient.
Specialist Involvement Required
Adolescents using GLP-1 medications should be managed by a pediatric endocrinologist or adolescent medicine specialist, not general telehealth platforms. Close monitoring of growth, nutrition, and psychological well-being is essential.
Nutritional Considerations
Growing teenagers have higher nutritional demands. Appetite suppression from GLP-1 medications must be balanced against requirements for calcium, iron, protein, and other nutrients essential for adolescent development.
When You Turn 18
Once you reach 18, you become eligible for adult GLP-1 programs, including compounded options. Trimi offers compounded semaglutide at $99/mo and compounded tirzepatide at $125/mo, with medical consultations included.
To qualify, you typically need a BMI of 30 or greater, or a BMI of 27+ with at least one weight-related health condition such as high blood pressure, high cholesterol, or type 2 diabetes.
Frequently Asked Questions
At what age are GLP-1 medications FDA-approved for weight loss?
Semaglutide (Wegovy) is FDA-approved for weight management in patients aged 12 and older with obesity. Liraglutide (Saxenda) is also approved for ages 12+. Tirzepatide approval for adolescents is still being studied. Most compounded medications and telehealth platforms require patients to be 18+.
Can my teenager get compounded semaglutide?
Most compounded medication providers, including Trimi, serve adult patients aged 18 and older. Adolescents requiring GLP-1 therapy should work with a pediatric endocrinologist or obesity medicine specialist who can prescribe brand-name FDA-approved options.
What are the risks of GLP-1 medications for growing adolescents?
Key concerns include effects on bone density during growth, nutritional adequacy during a period of rapid development, psychological impacts on body image, and the lack of long-term safety data specifically in the adolescent population.
Are there non-medication weight loss options for teens?
Yes, first-line treatments for adolescent obesity include structured family-based behavioral interventions, dietary counseling, increased physical activity, and addressing underlying psychological factors. Medication is typically reserved for teens who haven't responded to lifestyle changes.
Will GLP-1 medications affect puberty or growth?
Current data from adolescent trials has not shown significant effects on linear growth or pubertal development. However, adequate nutrition is critical during adolescence, and the appetite-suppressing effects of GLP-1s require careful monitoring to ensure teens meet nutritional needs.
Ready to Start Your Weight Loss Journey?
If you are 18 or older, Trimi offers affordable GLP-1 therapy with full medical support. Semaglutide from $99/mo, tirzepatide from $125/mo.
Explore Treatment OptionsSources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).